Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
53
NMPA:53
Drug Approvals
Abiraterone Acetate Tablets
- Product Name
- 醋酸阿比特龙片
- Approval Number
- 国药准字H20193276
- Approval Date
- Sep 12, 2024
NMPA
Mirabegron Sustained-release Tablets
- Product Name
- 米拉贝隆缓释片
- Approval Number
- 国药准字H20243715
- Approval Date
- May 15, 2024
NMPA
Nifedipine Controlled-release Tablets
- Product Name
- 硝苯地平控释片
- Approval Number
- 国药准字H20243688
- Approval Date
- May 15, 2024
NMPA
Rabeprazole Sodium Enteric-coated Tablets
- Product Name
- 雷贝拉唑钠肠溶片
- Approval Number
- 国药准字H20234002
- Approval Date
- Aug 1, 2023
NMPA
Doxazosin Mesylate Extended Release Tablets
- Product Name
- 甲磺酸多沙唑嗪缓释片
- Approval Number
- 国药准字H20233967
- Approval Date
- Jul 25, 2023
NMPA
Posaconazole Enteric-coated Tablets
- Product Name
- 泊沙康唑肠溶片
- Approval Number
- 国药准字H20233962
- Approval Date
- Jul 25, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found